Large cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighty- seven cases  Hidefumi Takei, MDa,b, Hisao Asamura, MDb, Arafumi Maeshima,

Slides:



Advertisements
Similar presentations
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Advertisements

Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas  Alexandre M Ab' Saber, MD, Ledo Mazzei Massoni Neto,
Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung  Rira Hoshi, CT, Noriyuki Furuta,
Steven Q. Wang, MD, Leonard H. Goldberg, MD, FRCP 
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
CD47 expression for in situ and invasive cutaneous epithelial lesions
Michael F. Nentwich, MD, Benjamin A. Bohn, MD, Faik G
Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.
Gastroesophageal tumor embolization to the popliteal arteries
Molecular Markers Help Characterize Neuroendocrine Lung Tumors
Intimal-type primary sarcoma of the thoracic aorta presenting as a saccular false aneurysm: Report of a case with evidence of rhabdomyosarcomatous differentiation 
Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,
Large Cell Neuroendocrine Carcinoma of the Mediastinum with α-Fetoprotein Production  Ken Takezawa, MD, Isamu Okamoto, MD, PhD, Junya Fukuoka, MD, PhD,
Sarcomatous mesothelioma in the left ventricle: A rare entity
David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L
Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis 
Intrapulmonary benign fibrous tumor of the pleura
Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion  Kenji Suzuki, MD, Hisao.
Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 
Nodular Lymphoid Hyperplasia of the Lung: A Very Rare Disease Entity
Successful localization and treatment for ectopic adrenocorticotrophic hormone secretion in a rare case of possible Tx N2 M0 carcinoid tumor with Cushing.
Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors  Akira Iyoda, MD, Kenzo Hiroshima, MD, Masayuki Baba,
Preoperative evidence of circulating tumor cells by means of reverse transcriptase- polymerase chain reaction for carcinoembryonic antigen messenger RNA.
The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer  J. Buhr,
A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer.
Management of patients with intramural hematoma involving the ascending aorta  Yoshimasa Moizumi, MDa, Tsunehiro Komatsu, MDa, Naotaka Motoyoshi, MDa,
Amy S. Colwell, MDa. , Jonathan D'Cunha, MD, PhDb. , Sara O
Relation Between Thin-Section Computed Tomography and Clinical Findings of Mucinous Adenocarcinoma  Hajime Watanabe, MD, Haruhiro Saito, MD, Tomoyuki.
Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis 
The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer  Yukito Ichinose, MDa, Tokujiro.
A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions  Hisao Asamura, MD, Kenji Suzuki,
Occult active giant cell aortitis necessitating surgical repair
Support Your Specialty
Thymic neuroendocrine carcinoma (carcinoid): A clinicopathologic study of fourteen cases  Vincent Thomas de Montpréville, MDa, Paolo Macchiarini, MDb,
Aggressive management of lung donors classified as unacceptable: Excellent recipient survival one year after transplantation  Michaela Straznicka, MDa,
Staged closure of tracheogastrocutaneous fistula after esophagectomy for infiltrative granular cell tumor  Robert Merritt, MD, Steven M. Zeitels, MD,
Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung  Rira Hoshi, CT, Noriyuki Furuta,
Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993  Kunihiko Inoue, MDa, Masami.
Nael Martini, MDa, Muhammad B. Zaman, MDb, Manjit S
Living-donor lobar lung transplantation for bronchiolitis obliterans after Stevens-Johnson syndrome  Hiroshi Date, MDa, Yoshifumi Sano, MDa, Motoi Aoe,
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis  Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification  Jacek Jassem, MDa, Jan.
A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: Initial results  Manjit S. Bains, MDa, Alexander Stojadinovic,
Differential diagnosis of thymic carcinoma and lung carcinoma with the use of antibodies to cytokeratins  Ichiro Fukai, MDa, Akira Masaoka, MD, PhDa,
Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung  Yukio Watanabe, MD, Koji.
Surgical treatment of pulmonary artery sarcoma
“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin- section computed tomographic scan  Kenji Suzuki, MD, Hisao Asamura,
The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations  Kojiro Furukawa, MDa, Hitoshi Ohteki, MDa, Kenji Hirahara,
Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival: Its Implications for the Forthcoming TNM Staging Based on a Large-Scale.
Lymph Node Metastasis In Small Peripheral Adenocarcinoma Of The Lung
Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical.
Analysis of edema fluids and histologic features of the lung in reexpansion pulmonary edema during video-assisted thoracoscopic surgery  Satoshi Suzuki,
Prognosis and “granularity”: Building on staging foundations?
O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M
The adenosine triphosphate–sensitive potassium channel opener nicorandil protects the ischemic rabbit spinal cord  Yutaka Wakamatsu, MDa, Norihiko Shiiya,
Bilobectomy for massive hemoptysis after bilateral lung transplantation  Stefan Guth, MDa, Eckhard Mayer, MDa, Berthold Fischer, MDb, Jana Lill, MDb, Norbert.
Primary choriocarcinoma of the lung
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tai Ji: The law of inflammatory response
Second operation for upper mediastinal lymphadenopathy after complete resection for cancer of the left lung  Masami Sato, MDa, b, Teruaki Koike, MDa,
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Thomas J. Kirby, MDa (by invitation), Michael J
Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker  Adnan Sayar,
Aritoshi Hattori, MD, Kenji Suzuki, MD 
Analysis of Differentially Expressed Genes in Neuroendocrine Carcinomas of the Lung  Chigusa Okubo, MS, Yuko Minami, MD, Ryota Tanaka, MD, Teruhito Uchihara,
Left Pneumonectomy for Lung Cancer After Correction of Contralateral Partial Anomalous Pulmonary Venous Return  Hiroyuki Sakurai, MD, Haruhiko Kondo,
Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non–small cell carcinoma  Akira Iyoda, MD, Kenzo.
Pulmonary transplantation for advanced bronchioloalveolar carcinoma
Presentation transcript:

Large cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighty- seven cases  Hidefumi Takei, MDa,b, Hisao Asamura, MDb, Arafumi Maeshima, MDc, Kenji Suzuki, MDb, Haruhiko Kondo, MDb, Toshiro Niki, MDc, Tesshi Yamada, MDc, Ryosuke Tsuchiya, MDa,b, Yoshihiro Matsuno, MDa  The Journal of Thoracic and Cardiovascular Surgery  Volume 124, Issue 2, Pages 285-292 (August 2002) DOI: 10.1067/mtc.2002.122523 Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 A, Representative photomicrograph of LCNEC. Organoid pattern, palisading, and necrosis are shown. (Hematoxylin and eosin; original magnification 100×.) B, Tumor cells are large and polygonal with abundant and finely granular cytoplasm, easily discernible nucleoli in some cells. Note also rosette-like structures. (Hematoxylin and eosin; original magnification 400×.) The Journal of Thoracic and Cardiovascular Surgery 2002 124, 285-292DOI: (10.1067/mtc.2002.122523) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 2 Representative staining of chromogranin A in LCNEC cases: A, Focal; B, patchy; C, diffuse. (Immunostain; original magnification 400×.) The Journal of Thoracic and Cardiovascular Surgery 2002 124, 285-292DOI: (10.1067/mtc.2002.122523) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 3 Survival curves of patients with LCNEC (n = 87), other poorly differentiated NSCLCs (n = 426), LCC (n = 102), and SCLC (n = 31) for all stages. The Journal of Thoracic and Cardiovascular Surgery 2002 124, 285-292DOI: (10.1067/mtc.2002.122523) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 4 Survival curves of 41 patients with LCNEC of stage I and 126 patients with other poorly differentiated NSCLCs of stage I (P =.003, log-rank test). The Journal of Thoracic and Cardiovascular Surgery 2002 124, 285-292DOI: (10.1067/mtc.2002.122523) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 5 Survival curves of 41 patients with LCNEC of stage I and 29 patients of LCC of stage I (P =.03, log-rank test). The Journal of Thoracic and Cardiovascular Surgery 2002 124, 285-292DOI: (10.1067/mtc.2002.122523) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

Fig. 6 Survival curves of 41 patients with LCNEC of stage I and 9 patients with SCLC of stage I (P =.87, log-rank test). The Journal of Thoracic and Cardiovascular Surgery 2002 124, 285-292DOI: (10.1067/mtc.2002.122523) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions